ONO PHARMACEUTICAL CO., LTD.
Patent Applications and Registrations
Patent applications and USPTO patent grants for ONO PHARMACEUTICAL CO., LTD..The latest application filed is for "hydantoin derivative".
Company Profile
140.200.200
Trademarks
- ONO PHARMACEUTICAL CO., LTD. - Osaka JP
- ONO PHARMACEUTICAL CO., LTD. - Osaka-shi, Osaka JP
- ONO PHARMACEUTICAL CO., LTD. - Osaka-shi JP
- ONO PHARMACEUTICAL CO., LTD - Osaka JP
- Ono Pharmaceutical Co., Ltd. - Chuo-ku, Osaka-shi, Osaka N/A JP
- Ono Pharmaceutical Co., Ltd. -
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Hydantoin Derivative App 20220306640 - NISHIOKA; Yota ; et al. | 2022-09-29 |
| Compound Having Kdm5 Inhibitory Activity And Pharmaceutical Use Thereof App 20220289751 - KAKUUCHI; Akito ; et al. | 2022-09-15 |
| Salt And Crystal Form Of Compound Having Agonistic Activity To S1p5 Receptor App 20220289675 - OTANI; Shuhei ; et al. | 2022-09-15 |
| Bispecific Antibody App 20220281977 - SHIBAYAMA; Shiro ; et al. | 2022-09-08 |
| Biomarkers For Determining The Efficacy Of Immune Checkpoint Inhibitors App 20220283167 - NISHIKAWA; Hiroyoshi ; et al. | 2022-09-08 |
| Immunosuppressant App 20220227887 - OKAZAKI; Taku ; et al. | 2022-07-21 |
| Dp Antagonist App 20220204468 - ASADA; Masaki ; et al. | 2022-06-30 |
| Bispecific Antibody App 20220185885 - SHIBAYAMA; Shiro ; et al. | 2022-06-16 |
| Purinone Derivative Hydrochloride App 20220177474 - YAMAMOTO; Shingo ; et al. | 2022-06-09 |
| DP antagonist Grant 11,319,296 - Asada , et al. May 3, 2 | 2022-05-03 |
| Pharmaceutical Composition for Treating Tumor App 20220117933 - Semba; Taro ; et al. | 2022-04-21 |
| Purinone derivative hydrochloride Grant 11,292,795 - Yamamoto , et al. April 5, 2 | 2022-04-05 |
| A Method For Treating Swi/snf Complex-deficient Cancers Comprising Glutathione (gsh) Metabolic Pathway Inhibitor App 20220087987 - OGIWARA; Hideaki ; et al. | 2022-03-24 |
| Benzene Derivative App 20220089532 - NOJIMA; Shoji ; et al. | 2022-03-24 |
| Benzene derivative Grant 11,261,154 - Nojima , et al. March 1, 2 | 2022-03-01 |
| Compounds Having S1p5 Receptor Agonistic Activity App 20220055986 - WATANABE; Toshihide ; et al. | 2022-02-24 |
| Tricyclic Spiro Compound App 20220048881 - ASADA; Masaki ; et al. | 2022-02-17 |
| Dp Antagonist App 20220033371 - ASADA; Masaki ; et al. | 2022-02-03 |
| Immunosuppresive Agent App 20220025051 - OKAZAKI; Taku ; et al. | 2022-01-27 |
| Treatment Of Cancer By Combination Of Immune Checkpoint Inhibitor And Folfirinox Therapy App 20220008421 - KIMURA; Keisuke ; et al. | 2022-01-13 |
| Biomarker for diagnosis of irritable bowel syndrome Grant 11,215,607 - Fukudo , et al. January 4, 2 | 2022-01-04 |
| Novel Crystal Of (3s)-3-[2-(6-amino-2-fluoropyridin-3-yl)-4-fluoro-1h-imidazol-5-yl]-7-[5-- Chloro-2-(1h-tetrazol-1-yl)phenyl]-2,3-dihydroindolizin-5(1h)-one App 20210395250 - FUJITO; Takayuki ; et al. | 2021-12-23 |
| Compounds having S1P5 receptor agonistic activity Grant 11,198,672 - Watanabe , et al. December 14, 2 | 2021-12-14 |
| Tricyclic spiro compound Grant 11,192,876 - Asada , et al. December 7, 2 | 2021-12-07 |
| Novel Salt Of 4-({(4s)-1-(4-carbamimidoylbenzoyl)-4-[4(methylsulfonyl)piperazin-1-yl]-l- -prolyl}amino) Benzoic Acid And Novel Crystal Form Thereof App 20210371379 - NISHIYAMA; Taihei ; et al. | 2021-12-02 |
| Sting Agonistic Compound App 20210363166 - HANADA; Ryosuke ; et al. | 2021-11-25 |
| Activator Of Trek (twik Related K+ Channels) Channels App 20210347773 - LINDSLEY; Craig W. ; et al. | 2021-11-11 |
| Benzene Derivative App 20210332009 - NOJIMA; Shoji ; et al. | 2021-10-28 |
| Bispecific Antibody App 20210332134 - SHIBAYAMA; Shiro ; et al. | 2021-10-28 |
| STING agonistic compound Grant 11,130,773 - Hanada , et al. September 28, 2 | 2021-09-28 |
| Sting Agonistic Compound App 20210253615 - HANADA; Ryosuke ; et al. | 2021-08-19 |
| Bispecific antibody Grant 11,091,550 - Shibayama , et al. August 17, 2 | 2021-08-17 |
| Therapeutic Agent For Cartilage-related Disease App 20210222177 - TSUMORI; Yuki ; et al. | 2021-07-22 |
| Combination comprising EP4 antagonist and immune checkpoint inhibitor Grant 11,065,226 - Yoshida , et al. July 20, 2 | 2021-07-20 |
| Bispecific Antibody App 20210214441 - SHIBAYAMA; Shiro ; et al. | 2021-07-15 |
| BRK inhibitory compound Grant 11,052,091 - Yamamoto , et al. July 6, 2 | 2021-07-06 |
| Biomarkers for determining the effectiveness of immune checkpoint inhibitors App 20210198361 - NISHIKAWA; Hiroyoshi ; et al. | 2021-07-01 |
| Activator of TREK (TWIK RElated K.sup.+ channels) channels Grant 11,046,683 - Lindsley , et al. June 29, 2 | 2021-06-29 |
| Bicyclic Compound And Use Thereof For Medical Purposes App 20210169842 - KAMBE; Tohru ; et al. | 2021-06-10 |
| Ep4 Antagonist App 20210163466 - ASADA; Masaki ; et al. | 2021-06-03 |
| Substituted Pyrrolidines As Factor Xia Inhibitors For The Treatment Thromboembolic Diseases App 20210147403 - IMAGAWA; Akira ; et al. | 2021-05-20 |
| PREVENTIVE AND/OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE COMPRISING COMPOUND HAVING Btk INHIBITORY ACTIVITY AS ACTIVE INGREDIENT App 20210113568 - ARIZA; Yuko | 2021-04-22 |
| Therapeutic Agent For Glaucoma Comprising Fp Agonist And Blocker App 20210085636 - YAMANE; Shinsaku ; et al. | 2021-03-25 |
| Compounds Having S1p5 Receptor Agonistic Activity App 20210087141 - WATANABE; Toshihide ; et al. | 2021-03-25 |
| Bicyclic compound and use thereof for medical purposes Grant 10,940,134 - Kambe , et al. March 9, 2 | 2021-03-09 |
| Methods of producing anamorelin hydrochloride having controlled chloride content Grant 10,905,737 - Kuwabe , et al. February 2, 2 | 2021-02-02 |
| Method for producing bicyclic compound Grant 10,899,729 - Moriguchi , et al. January 26, 2 | 2021-01-26 |
| Purinone Derivative Hydrochloride App 20210009593 - YAMAMOTO; Shingo ; et al. | 2021-01-14 |
| Dihydroindolizinone Derivative App 20210009586 - TANAKA; Motoyuki ; et al. | 2021-01-14 |
| Method For Assisting Determination Of Efficacy Of Immune Checkpoint Inhibitor App 20210003579 - HONJO; Tasuku ; et al. | 2021-01-07 |
| CANCER TREATMENT METHOD USING Trk INHIBITOR AND KINASE INHIBITOR IN COMBINATION App 20210000830 - KOZAKI; Ryohei ; et al. | 2021-01-07 |
| Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases Grant 10,882,855 - Imagawa , et al. January 5, 2 | 2021-01-05 |
| Hmgn Partial Peptide And Cancer Therapy Using The Same App 20200407408 - MATSUSHIMA; Kouji ; et al. | 2020-12-31 |
| Quinoline Derivative App 20200392110 - INUKAI; Takayuki ; et al. | 2020-12-17 |
| Phenyl derivative Grant 10,835,520 - Naganawa , et al. November 17, 2 | 2020-11-17 |
| Ethane-sulfonate salt of quinoline derivative Grant 10,836,747 - Nekado , et al. November 17, 2 | 2020-11-17 |
| Dihydroindolizinone derivative Grant 10,815,233 - Tanaka , et al. October 27, 2 | 2020-10-27 |
| Therapeutic Agent For Solid Cancers, Which Comprises Axl Inhibitor As Active Ingredient App 20200330453 - TAKAYAMA; Koichi ; et al. | 2020-10-22 |
| Purinone derivative hydrochloride Grant 10,807,981 - Yamamoto , et al. October 20, 2 | 2020-10-20 |
| Method For Producing Na Ve Pluripotent Stem Cells App 20200325453 - OKANO; Hideyuki ; et al. | 2020-10-15 |
| Bispecific Antibody App 20200317783 - SHIBAYAMA; Shiro ; et al. | 2020-10-08 |
| Trk-inhibiting compound Grant 10,765,676 - Takeuchi , et al. Sep | 2020-09-08 |
| Methods Of Producing Anamorelin Hydrochloride Having Controlled Chloride Content App 20200276259 - Kuwabe; Shin-itsu ; et al. | 2020-09-03 |
| Method for producing naive pluripotent stem cells Grant 10,738,280 - Okano , et al. A | 2020-08-11 |
| Tetrahydronaphthalene derivative Grant 10,730,830 - Watanabe , et al. | 2020-08-04 |
| Pyrimidinone and its derivatives inhibiting factor XIa Grant 10,717,738 - Courtney , et al. | 2020-07-21 |
| Therapeutic Agent For Cancer Containing Axl Inhibitor As Active Ingredient App 20200197385 - YASUHIRO; Tomoko ; et al. | 2020-06-25 |
| Prophylactic and/or therapeutic agent for fibromyalgia Grant 10,675,275 - Katsumata , et al. | 2020-06-09 |
| KCNQ2-5 channel activator Grant 10,676,438 - Yashiro , et al. | 2020-06-09 |
| Quinoline derivative Grant 10,676,462 - Inukai , et al. | 2020-06-09 |
| Combination Therapy Of An Anti Cd20 Antibody With A Btk Inhibitor App 20200171153A1 - | 2020-06-04 |
| Kcnq2-5 Channel Activator App 20200157050 - YASHIRO; Kentaro ; et al. | 2020-05-21 |
| Therapeutic agent for autoimmune diseases comprising PD-1 agonist Grant 10,647,770 - Shibayama , et al. | 2020-05-12 |
| Dihydroindolizinone Derivative App 20200140435 - TANAKA; Motoyuki ; et al. | 2020-05-07 |
| Monoclonal Antibodies to Programmed Death 1 (PD-1) App 20200138945A1 - | 2020-05-07 |
| Method for treating brain tumors Grant 10,617,667 - Okada , et al. | 2020-04-14 |
| Tricyclic Spiro Compound App 20200102284 - ASADA; Masaki ; et al. | 2020-04-02 |
| Bicyclic Compound And Use Thereof For Medical Purposes App 20200093781 - KAMBE; Tohru ; et al. | 2020-03-26 |
| Methods of producing anamorelin hydrochloride having controlled chloride content Grant 10,576,122 - Kuwabe , et al. | 2020-03-03 |
| Immunopotentiative Composition App 20200062846 - HONJO; Tasuku ; et al. | 2020-02-27 |
| KCNQ2-5 channel activator Grant 10570093 - | 2020-02-25 |
| Purinone Derivative App 20200048256 - YAMAMOTO; Shingo ; et al. | 2020-02-13 |
| Dihydroindolizinone derivative Grant 10,550,119 - Tanaka , et al. Fe | 2020-02-04 |
| Tricyclic spiro compound Grant 10,538,502 - Asada , et al. Ja | 2020-01-21 |
| Quinoline Derivative App 20200002313 - INUKAI; Takayuki ; et al. | 2020-01-02 |
| Brk Inhibitory Compound App 20200000810 - YAMAMOTO; Shingo ; et al. | 2020-01-02 |
| Compound Having Somatostatin Receptor Agonistic Activity And Pharmaceutical Use Thereof App 20200000816 - ISHIDA; Akiharu ; et al. | 2020-01-02 |
| KCNQ2-5 channel activator Grant 10,519,105 - Yashiro , et al. Dec | 2019-12-31 |
| Ethane-sulfonate Salt Of Quinoline Derivative App 20190389837 - NEKADO; Takahiro ; et al. | 2019-12-26 |
| Quinoline derivative Grant 10,501,442 - Inukai , et al. Dec | 2019-12-10 |
| Purinone derivative Grant 10,487,085 - Yamamoto , et al. Nov | 2019-11-26 |
| Dihydroindolizinone Derivative App 20190352304 - TANAKA; Motoyuki ; et al. | 2019-11-21 |
| Activator Of Trek (twik Related K+ Channels) Channels App 20190322662 - LINDSLEY; Craig W ; et al. | 2019-10-24 |
| Brk Inhibitory Compound App 20190315756 - YAMAMOTO; Shingo ; et al. | 2019-10-17 |
| Purinone Derivative Hydrochloride App 20190315748 - YAMAMOTO; Shingo ; et al. | 2019-10-17 |
| Monoclonal antibodies to programmed death 1 (PD-1) Grant 10,441,655 - Korman , et al. Oc | 2019-10-15 |
| Agent For Suppressing Post-surgical Cancer Recurrence And/or Metastasis App 20190307761 - SAKAMOTO; Atsuhiro ; et al. | 2019-10-10 |
| Prophylactic agent and/or therapeutic agent for diffuse large B-cell lymphoma Grant 10,426,778 - Yoshizawa , et al. October 1, 2 | 2019-10-01 |
| Dihydroindolizinone derivative Grant 10,407,426 - Tanaka , et al. Sept | 2019-09-10 |
| Acid-addition salt of Trk-inhibiting compound Grant 10,399,959 - Takeuchi , et al. Sep | 2019-09-03 |
| Substituted Pyrrolidines As Factor Xia Inhibitors For The Treatment Thromboembolic Diseases App 20190263795 - IMAGAWA; Akira ; et al. | 2019-08-29 |
| Combination Comprising Ep4 Antagonist And Immune Checkpoint Inhibitor App 20190255013 - YOSHIDA; Takao ; et al. | 2019-08-22 |
| Compound having EP2 agonist activity Grant 10,385,045 - Ogawa , et al. A | 2019-08-20 |
| Brk inhibitory compound Grant 10,377,759 - Yamamoto , et al. A | 2019-08-13 |
| Purinone derivative hydrochloride Grant 10,370,377 - Yamamoto , et al. | 2019-08-06 |
| Trk-INHIBITING COMPOUND App 20190231777 - TAKEUCHI; Jun ; et al. | 2019-08-01 |
| Methods Of Producing Anamorelin Hydrochloride Having Controlled Chloride Content App 20190231843 - Kuwabe; Shin-itsu ; et al. | 2019-08-01 |
| Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases Grant 10,336,741 - Imagawa , et al. | 2019-07-02 |
| Inhibitors of Bruton's tyrosine kinase Grant 10,314,844 - Lee , et al. | 2019-06-11 |
| Purinone Derivative App 20190169192 - YAMAMOTO; Shingo ; et al. | 2019-06-06 |
| Trk-inhibiting compound Grant 10,300,060 - Takeuchi , et al. | 2019-05-28 |
| Methods of producing anamorelin hydrochloride having controlled chloride content Grant 10,300,105 - Kuwabe , et al. | 2019-05-28 |
| Crystal Polymorphism Of Kcnq2-5 Channel Activator App 20190135755 - YASHIRO; Kentaro ; et al. | 2019-05-09 |
| Quinoline Derivative App 20190135785 - Inukai; Takayuki ; et al. | 2019-05-09 |
| Kcnq2-5 Channel Activator App 20190127320 - YASHIRO; Kentaro ; et al. | 2019-05-02 |
| Method For Treating Brain Tumors App 20190125720 - Okada; Hideho ; et al. | 2019-05-02 |
| Bicyclic Compound And Use Thereof For Medical Purposes App 20190111019 - KAMBE; Tohru ; et al. | 2019-04-18 |
| Drug For Cancer Therapy Characterized In That Axl Inhibitor And Immune Checkpoint Inhibitor Are Administered In Combination App 20190099413 - TANAKA; Kohei ; et al. | 2019-04-04 |
| Process for producing purinone derivative Grant 10,239,879 - Suzuki , et al. | 2019-03-26 |
| Purinone derivative Grant 10,233,185 - Yamamoto , et al. | 2019-03-19 |
| Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes Grant 10,214,540 - Ishida , et al. Feb | 2019-02-26 |
| Combination Of A Btk Inhibitor And A Checkpoint Inhibitor For Treating Cancers App 20190054090 - Venkataraman; Sriram ; et al. | 2019-02-21 |
| Prophylactic Agent And/or Therapeutic Agent For Diffuse Large B-cell Lymphoma App 20190054091 - YOSHIZAWA; Toshio ; et al. | 2019-02-21 |
| Quinoline derivative Grant 10,208,034 - Inukai , et al. Feb | 2019-02-19 |
| Quinoline derivative Grant 10,208,022 - Inukai , et al. Feb | 2019-02-19 |
| Bicyclic compound and use thereof for medical purposes Grant 10,201,520 - Kambe , et al. Feb | 2019-02-12 |
| KCNQ2-5 channel activator Grant 10,196,358 - Yashiro , et al. Fe | 2019-02-05 |
| Phenyl Derivative App 20190030010 - NAGANAWA; Atsushi ; et al. | 2019-01-31 |
| Tetrahydronaphthalene Derivative App 20190031605 - WATANABE; Toshihide ; et al. | 2019-01-31 |
| Methods Of Producing Anamorelin Hydrochloride Having Controlled Chloride Content App 20190000914 - Kuwabe; Shin-itsu ; et al. | 2019-01-03 |
| Combination Therapies For Treating B-cell Malignancies App 20180353512 - Collins; Helen ; et al. | 2018-12-13 |
| Kcnq2-5 Channel Activator App 20180346422 - Yashiro; Kentaro ; et al. | 2018-12-06 |
| Prophylactic agent and/or therapeutic agent for diffuse large B-cell lymphoma Grant 10,137,129 - Yoshizawa , et al. November 27, 2 | 2018-11-27 |
| Dihydroindolizinone Derivative App 20180334458 - TANAKA; Motoyuki ; et al. | 2018-11-22 |
| Tricyclic Spiro Compound App 20180319764 - ASADA; Masaki ; et al. | 2018-11-08 |
| Phenyl derivative Grant 10,117,861 - Naganawa , et al. November 6, 2 | 2018-11-06 |
| Fused Imidazole Compounds App 20180289718 - SAITO; Tetsuji ; et al. | 2018-10-11 |
| Tricyclic spiro compound Grant 10,077,247 - Asada , et al. September 18, 2 | 2018-09-18 |
| Quinoline Derivative App 20180258072 - INUKAI; Takayuki ; et al. | 2018-09-13 |
| Trk-INHIBITING COMPOUND App 20180256573 - TAKEUCHI; Jun ; et al. | 2018-09-13 |
| Dihydroindolizinone derivative Grant 10,065,955 - Tanaka , et al. September 4, 2 | 2018-09-04 |
| Purinone Derivative Hydrochloride App 20180244675 - YAMAMOTO; Shingo ; et al. | 2018-08-30 |
| Immunity Enhancing Agent For Cancer By Allergin-1 Antagonist App 20180244771 - SHIBAYAMA; Shiro ; et al. | 2018-08-30 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20180243311 - Lee; Seung H. ; et al. | 2018-08-30 |
| Compound Having Ep2 Agonist Activity App 20180215747 - OGAWA; Seiji ; et al. | 2018-08-02 |
| Compound Having Agonistic Activity On Somatostatin Receptor, And Use Thereof For Medical Purposes App 20180194775 - ISHIDA; Akiharu ; et al. | 2018-07-12 |
| Fused imidazole compounds Grant 10,016,439 - Saito , et al. July 10, 2 | 2018-07-10 |
| Brk Inhibitory Compound App 20180186800 - YAMAMOTO; Shingo ; et al. | 2018-07-05 |
| Purinone Derivative App 20180170933 - YAMAMOTO; Shingo ; et al. | 2018-06-21 |
| Prophylactic And/or Therapeutic Agent For Fibromyalgia App 20180169077 - KATSUMATA; Seishi ; et al. | 2018-06-21 |
| Trk-inhibiting compound Grant 9,993,479 - Takeuchi , et al. June 12, 2 | 2018-06-12 |
| Quinoline derivative Grant 9,994,549 - Inukai , et al. June 12, 2 | 2018-06-12 |
| Purinone derivative hydrochloride Grant 9,981,966 - Yamamoto , et al. May 29, 2 | 2018-05-29 |
| Methods of producing anamorelin hydrochloride having controlled chloride content Grant 9,981,002 - Kuwabe , et al. May 29, 2 | 2018-05-29 |
| Tetrahydrocarboline derivative Grant 9,974,777 - Ohata , et al. May 22, 2 | 2018-05-22 |
| Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes Grant 9,975,904 - Ishida , et al. May 22, 2 | 2018-05-22 |
| Drug-eluting stent graft Grant 9,968,716 - Sawa , et al. May 15, 2 | 2018-05-15 |
| Bicyclic Compound And Use Thereof For Medical Purposes App 20180116995 - KAMBE; Tohru ; et al. | 2018-05-03 |
| Use Of Immunesuppressant Receptor App 20180118797 - ODANI; Tomoyuki ; et al. | 2018-05-03 |
| Methods of producing anamorelin hydrochloride having controlled chloride content Grant 9,956,261 - Kuwabe , et al. May 1, 2 | 2018-05-01 |
| Method For Extracting Lead Compound, Method For Selecting Drug Discovery Target, Device For Creating Scatter Diagram, And Data Visualization Method And Visualization Device App 20180089363 - KURONO; Masakuni ; et al. | 2018-03-29 |
| Purinone derivative Grant 9,926,322 - Yamamoto , et al. March 27, 2 | 2018-03-27 |
| Method For Producing Na Ve Pluripotent Stem Cells App 20180080009 - OKANO; Hideyuki ; et al. | 2018-03-22 |
| Process For Producing Purinone Derivative App 20180079751 - SUZUKI; Ryo ; et al. | 2018-03-22 |
| Purinone derivative hydrochloride Grant 9,896,453 - Yamamoto , et al. February 20, 2 | 2018-02-20 |
| Phenyl Derivative App 20180042908 - NAGANAWA; Atsushi ; et al. | 2018-02-15 |
| Bicyclic compound and use thereof for medical purposes Grant 9,889,114 - Kambe , et al. February 13, 2 | 2018-02-13 |
| Compound having selective EP2 agonist activity Grant 9,890,146 - Ogawa , et al. February 13, 2 | 2018-02-13 |
| Purinone derivative Grant 9,879,013 - Yamamoto , et al. January 30, 2 | 2018-01-30 |
| Methods of producing anamorelin hydrochloride having controlled chloride content Grant 9,872,883 - Kuwabe , et al. January 23, 2 | 2018-01-23 |
| Tetrahydrocarboline derivative Grant 9,862,721 - Ohata , et al. January 9, 2 | 2018-01-09 |
| Tricyclic Spiro Compound App 20180002308 - ASADA; Masaki ; et al. | 2018-01-04 |
| Use of immunesuppressant receptor Grant 9,856,299 - Odani , et al. January 2, 2 | 2018-01-02 |
| Quinoline Derivative App 20170349583 - INUKAI; Takayuki ; et al. | 2017-12-07 |
| Dihydroindolizinone Derivative App 20170349580 - TANAKA; Motoyuki ; et al. | 2017-12-07 |
| Trk-INHIBITING COMPOUND App 20170340634 - TAKEUCHI; Jun ; et al. | 2017-11-30 |
| Kcnq2-5 Channel Activator App 20170334855 - Yashiro; Kentaro ; et al. | 2017-11-23 |
| Phenyl derivative Grant 9,820,980 - Naganawa , et al. November 21, 2 | 2017-11-21 |
| Dihydronaphthalene Derivative App 20170327439 - KUSUMI; Kensuke ; et al. | 2017-11-16 |
| Therapeutic Agent For Autoimmune Diseases Comprising Pd-1 Agonist App 20170320949 - SHIBAYAMA; Shiro ; et al. | 2017-11-09 |
| KCNQ2-5 channel activator Grant 9,809,544 - Yashiro , et al. November 7, 2 | 2017-11-07 |
| Purinone Derivative App 20170313705 - YAMAMOTO; Shingo ; et al. | 2017-11-02 |
| Purinone Derivative Hydrochloride App 20170313706 - YAMAMOTO; Shingo ; et al. | 2017-11-02 |
| Compounds App 20170305917 - COURTNEY; Steve ; et al. | 2017-10-26 |
| Substance specific to human PD-1 Grant 9,783,609 - Honjo , et al. October 10, 2 | 2017-10-10 |
| ALXR agonist compound Grant 9,771,357 - Terakado , et al. September 26, 2 | 2017-09-26 |
| Trk-inhibiting compound Grant 9,763,943 - Takeuchi , et al. September 19, 2 | 2017-09-19 |
| Pyridinone and pyrimidinone derivatives as factor Xia Grant 9,732,085 - Courtney , et al. August 15, 2 | 2017-08-15 |
| Therapeutic agent for autoimmune diseases comprising PD-1 agonist Grant 9,701,749 - Shibayama , et al. July 11, 2 | 2017-07-11 |
| Left ventricular diastolic function improving agent Grant 9,682,065 - Kanaji , et al. June 20, 2 | 2017-06-20 |
| Phenyl derivative Grant 9,676,719 - Kusumi , et al. June 13, 2 | 2017-06-13 |
| Amine salt and crystals thereof Grant 9,643,940 - Tani , et al. May 9, 2 | 2017-05-09 |
| Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof Grant 9,643,951 - Ishida , et al. May 9, 2 | 2017-05-09 |
| Tetrahydrocarboline derivative Grant 9,636,330 - Ohata , et al. May 2, 2 | 2017-05-02 |
| Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes Grant 9,630,976 - Ishida , et al. April 25, 2 | 2017-04-25 |
| Advanced heart failure treatment material as myocardial/cardiovascular regeneration device Grant 9,597,436 - Sawa , et al. March 21, 2 | 2017-03-21 |
| Pyrrolo pyrimidine derivative Grant 9,586,967 - Inukai , et al. March 7, 2 | 2017-03-07 |
| Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases Grant 9,585,881 - Imagawa , et al. March 7, 2 | 2017-03-07 |
| Quinoline derivative Grant 9,573,935 - Inukai , et al. February 21, 2 | 2017-02-21 |
| (2R)-2-propyloctanoic acid for functional brain disease Grant 9,517,221 - Shinagawa , et al. December 13, 2 | 2016-12-13 |
| Trk-inhibiting compound Grant 9,498,453 - Takeuchi , et al. November 22, 2 | 2016-11-22 |
| Methods for treating cancer using anti-PD-1 antibodies Grant 9,492,540 - Korman , et al. November 15, 2 | 2016-11-15 |
| Monoclonal antibodies to Programmed Death 1 (PD-1) Grant 9,492,539 - Korman , et al. November 15, 2 | 2016-11-15 |
| Trk-inhibiting compound Grant 9,463,192 - Takeuchi , et al. October 11, 2 | 2016-10-11 |
| Immunopotentiative composition Grant 9,439,962 - Honjo , et al. September 13, 2 | 2016-09-13 |
| Prophylactic agent and/or therapeutic agent for diffuse large B-cell lymphoma Grant 9,416,131 - Yoshizawa , et al. August 16, 2 | 2016-08-16 |
| Immunopotentiative composition Grant 9,402,899 - Honjo , et al. August 2, 2 | 2016-08-02 |
| Methods of producing anamorelin hydrochloride having controlled chloride content Grant 9,403,867 - Kuwabe , et al. August 2, 2 | 2016-08-02 |
| Immunopotentiative composition Grant 9,393,301 - Honjo , et al. July 19, 2 | 2016-07-19 |
| Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases Grant 9,394,250 - Imagawa , et al. July 19, 2 | 2016-07-19 |
| Monoclonal antibodies to programmed death 1 (PD-1) Grant 9,387,247 - Korman , et al. July 12, 2 | 2016-07-12 |
| Bicyclic compound and use thereof for medical purposes Grant 9,388,157 - Kambe , et al. July 12, 2 | 2016-07-12 |
| Compound having acidic group which may be protected, and use thereof Grant 08618122 - | 2013-12-31 |
| Chemokine Receptor Antagonists And Use Thereof App 20120328627A1 - | 2012-12-27 |
| Crystal Comprising (2r)-2-propyloctanoic Acid And Amine App 20100331414A1 - | 2010-12-30 |
Company Registrations
| NCAGE Code | SDLP4 | ONO PHARMACEUTICAL CO., LTD. |
| CAGE Code | SDLP4 | ONO PHARMACEUTICAL CO., LTD. |
| S.A.M. Registration | SDLP4 [690571682] | ONO PHARMACEUTICAL CO., LTD. |
| SEC | 0000940821 | ONO PHARMACEUTICAL CO LTD |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 